This study is looking at the safety and outcomes for people who receive a heart transplant from a donor who had hepatitis C (HCV NAT+ donor organs). Researchers want to see if using these donor hearts, along with new treatments for hepatitis C, leads to good results for patients. You could join if you are 18 or older and have received a heart from a donor who tested positive for hepatitis C. This includes people who are having a re-transplant. The study will measure how many people get a heart transplant from an HCV NAT+ donor, how many are cured of hepatitis C, and the rate of primary graft dysfunction (when the new heart doesn't work well right away). The study is currently unclear on its status and plans to enroll 500 participants.

Study design

This is an observational study, meaning researchers will watch and collect information without giving specific treatments. It plans to include 500 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to 6.5 years to assess cure rates and for 30 days to assess primary graft dysfunction.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.